Abstract
Testing of all manufactured products and their ingredients for eye irritation is a regulatory requirement. In the last two decades, the development of alternatives to the in vivo Draize eye irritation test method has substantially advanced due to the improvements in primary cell isolation, cell culture techniques, and media, which have led to improved in vitro corneal tissue models and test methods. Most in vitro models for ocular toxicology attempt to reproduce the corneal epithelial tissue which consists of 4–5 layers of non-keratinized corneal epithelial cells that form tight junctions, thereby limiting the penetration of chemicals, xenobiotics, and pharmaceuticals. Also, significant efforts have been directed toward the development of more complex three-dimensional (3D) equivalents to study wound healing, drug permeation, and bioavailability. This review focuses on in vitro reconstructed 3D corneal tissue models and their utilization in ocular toxicology as well as their application to pharmacology and ophthalmic research. Current human 3D corneal epithelial cell culture models have replaced in vivo animal eye irritation tests for many applications, and substantial validation efforts are in progress to verify and approve alternative eye irritation tests for widespread use. The validation of drug absorption models and further development of models and test methods for many ophthalmic and ocular disease applications is required.
Similar content being viewed by others
References
Abdalkader R, Kamei KI (2020) Multi-corneal barrier-on-a-chip to recapitulate eye blinking shear stress forces. Lab Chip 20:1410–1417
Abdelkader H, Pierscionek B, Carew M, Wu Z, Alany RG (2015) Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals. Br Med Bull 113:59–71
Aberdam E, Petit I, Sangari L, Aberdam D (2017) Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing. PLoS One 12:e0179913
Abo T, Hilberer A, Behle-Wagner C, Watanabe M, Cameron D, Kirst A, Nukada Y, Yuki T, Araki D, Sakaguchi H, Itagaki H (2018) Predictive performance and inter-laboratory reproducibility in assessing eye irritation potential of water- and oil-soluble mixtures using the Short Time Exposure test method. Toxicol in Vitro 48:78–85
Adriaens E, Barroso J, Eskes C, Hoffmann S, McNamee P, Alepee N, Bessou-Touya S, De Smedt A, De Wever B, Pfannenbecker U, Tailhardat M, Zuang V (2014) Retrospective analysis of the Draize test for serious eye damage/eye irritation: importance of understanding the in vivo endpoints under UN GHS/EU CLP for the development and evaluation of in vitro test methods. Arch Toxicol 88:701–723
Adriaens E, Dierckens K, Bauters TG, Nelis HJ, van Goethem F, Vanparys P, Remon JP (2001) The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs. Pharm Res 18:937–942
Adriaens E, Guest R, Willoughby JA Sr, Fochtman P, Kandarova H, Verstraelen S, Van Rompay AR (2018a) CON4EI: Slug mucosal irritation (SMI) test method for hazard identification and labelling of serious eye damaging and eye irritating chemicals. Toxicol in Vitro 49:77–89
Adriaens E, Verstraelen S, Alepee N, Kandarova H, Drzewiecka A, Gruszka K, Guest R, Willoughby JA Sr, Van Rompay AR (2018b) CON4EI: Development of testing strategies for hazard identification and labelling for serious eye damage and eye irritation of chemicals. Toxicol in Vitro 49:99–115
Adriaens E, Willoughby JA Sr, Meyer BR, Blakeman LC, Alepee N, Fochtman P, Guest R, Kandarova H, Verstraelen S, Van Rompay AR (2018c) CON4EI: Short time exposure (STE) test method for hazard identification and labelling of eye irritating chemicals. Toxicol in Vitro 49:65–76
Agarwal P, Rupenthal ID (2016) In vitro and ex vivo corneal penetration and absorption models. Drug Deliv Transl Res 6:634–647
Alépée N, Adriaens E, Abo T, Bagley D, Desprez B, Hibatallah J, Mewes K, Pfannenbecker U, Sala À, Van Rompay AR, Verstraelen S, McNamee P (2019) Development of a defined approach for eye irritation or serious eye damage for neat liquids based on cosmetics Europe analysis of in vitro RhCE and BCOP test methods. Toxicol in Vitro 59:100–114
Alepee N, Bahinski A, Daneshian M, De Wever B, Fritsche E, Goldberg A, Hansmann J, Hartung T, Haycock J, Hogberg H, Hoelting L, Kelm JM, Kadereit S, McVey E, Landsiedel R, Leist M, Lubberstedt M, Noor F, Pellevoisin C, Petersohn D, Pfannenbecker U, Reisinger K, Ramirez T, Rothen-Rutishauser B, Schafer-Korting M, Zeilinger K, Zurich MG (2014) State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. Altex 31:441–477
Alepee N, Bessou-Touya S, Cotovio J, de Smedt A, de Wever B, Faller C, Jones P, Le Varlet B, Marrec-Fairley M, Pfannenbecker U, Tailhardat M, van Goethem F, McNamee P (2013) Cosmetics Europe multi-laboratory pre-validation of the SkinEthic reconstituted human corneal epithelium test method for the prediction of eye irritation. Toxicol in Vitro 27:1476–1488
Alepee N, Hibatallah J, Klaric M, Mewes KR, Pfannenbecker U, McNamee P (2016a) Assessment of cosmetic ingredients in the in vitro reconstructed human epidermis test method EpiSkin using HPLC/UPLC-spectrophotometry in the MTT-reduction assay. Toxicol in Vitro 33:105–117
Alepee N, Leblanc V, Adriaens E, Grandidier MH, Lelievre D, Meloni M, Nardelli L, Roper CS, Santirocco E, Toner F, Van Rompay A, Vinall J, Cotovio J (2016b) Multi-laboratory validation of SkinEthic HCE test method for testing serious eye damage/eye irritation using liquid chemicals. Toxicol in Vitro 31:43–53
Alépée N, Leblanc V, Grandidier MH, Teluob S, Tagliati V, Adriaens E, Michaut V (2020) Development of the SkinEthic HCE Time-to-Toxicity test method for identifying liquid chemicals not requiring classification and labelling and liquids inducing serious eye damage and eye irritation. Toxicol in Vitro 69:104960
Amano S, Mimura T, Yamagami S, Osakabe Y, Miyata K (2005) Properties of corneas reconstructed with cultured human corneal endothelial cells and human corneal stroma. Jpn J Ophthalmol 49:448–452
Amano S, Yamagami S, Mimura T, Uchida S, Yokoo S (2006) Corneal stromal and endothelial cell precursors. Cornea 25:S73–S77
Andrade WM, da Silva ACG, Moreira LC, Gomes T, Batista AC, Valadares MC (2020) Innovative strategy based on mechanisms to substitute animal testing for ocular toxicity assessment of agrochemical formulations market in Brazil. Toxicol in Vitro 66:104851
Araki-Sasaki K, Ohashi Y, Sasabe T, Hayashi K, Watanabe H, Tano Y, Handa H (1995) An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci 36:614–621
Argueso P, Gipson IK (2001) Epithelial mucins of the ocular surface: structure, biosynthesis and function. Exp Eye Res 73:281–289
Bai J, Fu H, Bazinet L, Birsner AE, D'Amato RJ (2020) A method for developing novel 3D cornea-on-a-chip using primary murine corneal epithelial and endothelial cells. Front Pharmacol 11:453
Balls M, Berg N, Bruner LH, Curren RD, de Silva O, Earl LK, Esdaile DJ, Fentem JH, Liebsch M, Ohno Y, Prinsen MK, Spielmann H, Worth AP (1999) Eye irritation testing: the way forward. The Report and Recommendations of ECVAM Workshop 34. Altern Lab Anim 27:53–77
Barile FA (2010) Validating and troubleshooting ocular in vitro toxicology tests. J Pharmacol Toxicol Methods 61:136–145
Barroso J, Ahn IY, Caldeira C, Carmichael PL, Casey W, Coecke S, Curren R, Desprez B, Eskes C, Griesinger C, Guo J, Hill E, Roi AJ, Kojima H, Li J, Lim CH, Moura W, Nishikawa A, Park H, Peng S, Presgrave O, Singer T, Sohn SJ, Westmoreland C, Whelan M, Yang X, Yang Y, Zuang V (2016) International harmonization and cooperation in the validation of alternative methods. Adv Exp Med Biol 856:343–386
Barroso J, Pfannenbecker U, Adriaens E, Alépée N, Cluzel M, De Smedt A, Hibatallah J, Klaric M, Mewes KR, Millet M, Templier M, McNamee P (2017) Cosmetics Europe compilation of historical serious eye damage/eye irritation in vivo data analysed by drivers of classification to support the selection of chemicals for development and evaluation of alternative methods/strategies: the Draize eye test Reference Database (DRD). Arch Toxicol 91:521–547
Barroso JF, Alepee N, Cole T, Freeman S, Liska R, McNamee P, Pfannenbecker U, Reus A, Rubingh C, Schaeffer MW, Zuang V, Eskes C, Griesinger C, T M (2014) The EURL ECVAM - Cosmetics Europe prospective validation study of Reconstructed human Cornea-like Epithelium (RhCE)-based test methods for identifying chemicals not requiring classification and labelling for serious eye damage/eye irritation. Publ Off Eur Union. https://doi.org/10.2787/41680
Becker U, Ehrhardt C, Schneider M, Muys L, Gross D, Eschmann K, Schaefer UF, Lehr CM (2008) A comparative evaluation of corneal epithelial cell cultures for assessing ocular permeability. Altern Lab Anim 36:33–44
Bennet D, Estlack Z, Reid T, Kim J (2018) A microengineered human corneal epithelium-on-a-chip for eye drops mass transport evaluation. Lab Chip 18:1539–1551
Blazka M, Harbell JW, Klausner M, Merrill JC, Kubilus J, Kloss C, Bagley DM (2003) Evaluating the ocular irritation potential of 54 test articles using the EpiOcular human tissue construct model (OCL-200). Toxicologist 72:221
Blazka ME, Diaco M, Harbell JW, Raabe H, Sizemore A, Wilt N, Bagley DM (2005) EpiOcular™ human cell construct: tissue viability and histological changes following exposure to surfactants. Toxicologist 85:409
Bradlaw J, Gupta K, Green S, Hill R, Wilcox N (1997) Practical application of non-whole animal alternatives: summary of IRAG workshop on eye irritation testing. Interagency Regulatory Alternatives Group. Food Chem Toxicol 35:175–178
Brantom PG, Bruner LH, Chamberlain M, De Silva O, Dupuis J, Earl LK, Lovell DP, Pape WJ, Uttley M, Bagley DM, Baker FW, Bracher M, Courtellemont P, Declercq L, Freeman S, Steiling W, Walker AP, Carr GJ, Dami N, Thomas G, Harbell J, Jones PA, Pfannenbecker U, Southee JA, Tcheng M, Argembeaux H, Castelli D, Clothier R, Esdaile DJ, Itigaki H, Jung K, Kasai Y, Kojima H, Kristen U, Larnicol M, Lewis RW, Marenus K, Moreno O, Peterson A, Rasmussen ES, Robles C, Stern M (1997) A summary report of the COLIPA international validation study on alternatives to the draize rabbit eye irritation test. Toxicol in Vitro 11:141–179
Bruner LH (1992) Alternatives to the use of animals in household product and cosmetic testing. J Am Vet Med Assoc 200:669–673
Bruner LH, Miller KR, Owicki JC, Parce JW, Muir VC (1991) Testing ocular irritancy in vitro with the silicon microphysiometer. Toxicol in Vitro 5:277–284
Burton AB, York M, Lawrence RS (1981) The in vitro assessment of severe eye irritants. Food Cosmet Toxicol 19:471–480
CA.GOV (2018) Senate Bill No. 1249. Animal testing: cosmetics. CHAPTER 899. An act to add Section 1834.9.5 to the Civil Code, relating to animal testing. https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201720180SB1249.
CD_76/768/EEC (2004) Timetables for the phasing-out of animal testing in the framework of the 7th Amendment to the Cosmetics Directive (Council Directive 76/768/EEC), COMMISSION OF THE EUROPEAN COMMUNITIES, available at: https://ec.europa.eu/docsroom/documents/13124/attachments/1/translations.
Ceriotti L, Balzaretti S, Barone S, Meloni M (2020) Eye irritation potential of microglycine and microglycine-containing ointments: an in vitro study on reconstructed human corneal epithelium. Clin Ophthalmol 14:257–267
Chacón M, Vázquez N, Berisa S, Persinal M, Sánchez M, Baamonde B, Alfonso JF, Fernández-Vega Cueto L, Merayo-Lloves J, Meana Á (2019) QobuR - a new in vitro human corneal epithelial model for preclinical drug screening. Eur J Pharm Biopharm 136:164–173
Chang JE, Basu SK, Lee VH (2000) Air-interface condition promotes the formation of tight corneal epithelial cell layers for drug transport studies. Pharm Res 17:670–676
Chapman S, Liu X, Meyers C, Schlegel R, McBride AA (2010) Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 120:2619–2626
Choi S, Lee M, Lee SH, Jung HS, Kim SY, Chung TY, Choe TB, Chun YJ, Lim KM (2015) Identification of cornifelin and early growth response-1 gene as novel biomarkers for in vitro eye irritation using a 3D reconstructed human cornea model MCTT HCE™. Arch Toxicol 89:1589–1598
Choksi NY, Truax J, Layton A, Matheson J, Mattie D, Varney T, Tao J, Yozzo K, McDougal AJ, Merrill J, Lowther D, Barroso J, Linke B, Casey W, Allen D (2019) United States regulatory requirements for skin and eye irritation testing. Cutan Ocul Toxicol 38:141–155
Cotovio J, Grandidier MH, Lelievre D, Bremond C, Amsellem C, Maloug S, Ovigne JM, Loisel-Joubert S, Lee AV, Minondo AM, Capallere C, Bertino B, Alepee N, Tinois-Tessonneaud E, de Fraissinette AB, Meunier JR, Leclaire J (2010) In vitro assessment of eye irritancy using the Reconstructed Human Corneal Epithelial SkinEthic HCE model: application to 435 substances from consumer products industry. Toxicol in Vitro 24:523–537
Cottin M, Zanvit A (1997) Fluorescein leakage test: a useful tool in ocular safety assessment. Toxicol in Vitro 11:399–405
Creager HM, Kumar A, Zeng H, Maines TR, Tumpey TM, Belser JA (2018) Infection and replication of influenza virus at the ocular surface. J Virol 92
Curren RD, Harbell JW (2002) Ocular safety: a silent (in vitro) success story. Altern Lab Anim 30(Suppl 2):69–74
da Silva ACG, Chialchia AR, de Castro EG, MRL ES, Arantes DAC, Batista AC, Kitten GT, Valadares MC (2020) A new corneal epithelial biomimetic 3D model for in vitro eye toxicity assessment: development, characterization and applicability. Toxicol in Vitro 62:104666
Deardorff PM, McKay TB, Wang S, Ghezzi CE, Cairns DM, Abbott RD, Funderburgh JL, Kenyon KR, Kaplan DL (2018) Modeling diabetic corneal neuropathy in a 3D in vitro cornea system. Sci Rep 8:17294
Desjardins P, Couture C, Germain L, Guérin SL (2019) Contribution of the WNK1 kinase to corneal wound healing using the tissue-engineered human cornea as an in vitro model. J Tissue Eng Regen Med 13:1595–1608
Donaldson K, Poland CA (2013) Nanotoxicity: challenging the myth of nano-specific toxicity. Curr Opin Biotechnol 24:724–734
Draize JH, Woodard G, Calvery HO (1944) Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–390
Du Y, Sundarraj N, Funderburgh ML, Harvey SA, Birk DE, Funderburgh JL (2007) Secretion and organization of a cornea-like tissue in vitro by stem cells from human corneal stroma. Invest Ophthalmol Vis Sci 48:5038–5045
Dua HS, Faraj LA, Said DG, Gray T, Lowe J (2013) Human corneal anatomy redefined: a novel pre-Descemetʼs layer (Duaʼs layer). Ophthalmology 120:1778–1785
Dumouchel JL, Chemuturi N, Milton MN, Camenisch G, Chastain J, Walles M, Sasseville V, Gunduz M, Iyer GR, Argikar UA (2018) Models and approaches describing the metabolism, transport, and toxicity of drugs administered by the ocular route. Drug Metab Dispos 46:1670–1683
EC (2006) Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), establishing a European Chemicals Agency. Off J Eur Union 1–849
EC (2020) Ban on animal testing, internal market, industry, entrepreneurship and SMEs. Available at: https://ec.europa.eu/growth/sectors/cosmetics/animal-testing_en; last accessed July 12, 2020.
ECHA (2017) Guidance on the application of the CLP criteria guidance to regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures; Version 5.0, July 2017. European Chemicals Agency, https://doi.org/10.2823/124801
ECVAM (2014) The EURL ECVAM - Cosmetics Europe prospective validation study of Reconstructed human Cornea-like Epithelium (RhCE)-based test methods for identifying chemicals not requiring classification and labelling for serious eye damage/eye irritation: validation study report. EUR 28125 EN; doi:https://doi.org/10.2787/41680. Available at: [http://publications.jrc.ec.europa.eu/repository/handle/JRC100280].
Eguizabal C, Aran B, Chuva de Sousa Lopes SM, Geens M, Heindryckx B, Panula S, Popovic M, Vassena R, Veiga A (2019) Two decades of embryonic stem cells: a historical overview. Hum Reprod Open 2019:hoy024
Elliott NT, Yuan F (2011) A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J Pharm Sci 100:59–74
Engelke M, Zorn-Kruppa M, Gabel D, Reisinger K, Rusche B, Mewes KR (2013) A human hemi-cornea model for eye irritation testing: quality control of production, reliability and predictive capacity. Toxicol in Vitro 27:458–468
EPA U (2015) Use of an alternate testing framework for classification of eye irritation potential of epa pesticide products. https://www.epa.gov/sites/production/files/2015-05/documents/eye_policy2015update.pdf. In Office of Pesticide Programs USEPA (ed). Washington DC
Erbani J, Aberdam D, Larghero J, Vanneaux V (2016) Pluripotent stem cells and other innovative strategies for the treatment of ocular surface diseases. Stem Cell Rev Rep 12:171–178
ESAC (2009) Statement on the scientific validity of cytotoxicity/cell-function based in vitro assay for eye irritation testing , 31St meeting of ECVAM Scientific Advisory Committee (ESAC) , 7-8 July 2009. European Commission- Joint Research Centre. Institute for Health and Consumer Protection. European Centre for Validation of Alternative Methods (ECVAM). Avai lable from: under Publications/ESAC statements.
Eskes C, Bostrom AC, Bowe G, Coecke S, Hartung T, Hendriks G, Pamies D, Piton A, Rovida C (2017) Good cell culture practices &in vitro toxicology. Toxicol in Vitro 45:272–277
Espana EM, Kawakita T, Liu CY, Tseng SC (2004) CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-beta1. Invest Ophthalmol Vis Sci 45:2985–2991
EU (2008) European Union, 2008. Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on Classification, Labelling and Packaging of Substances and Mixtures, Amending and Repealing Directives 67/548/EEC and 1999/45/EC, and Amending Regulation (EC) No 1907/2006
Fallacara A, Vertuani S, Panozzo G, Pecorelli A, Valacchi G, Manfredini S (2017) Novel artificial tears containing cross-linked hyaluronic acid: an in vitro re-epithelialization study. Molecules 22:2104
Feizi S (2018) Corneal endothelial cell dysfunction: etiologies and management. Ther Adv Ophthalmol 10:2515841418815802
Fernández-Pérez J, Ahearne M (2019) Influence of biochemical cues in human corneal stromal cell phenotype. Curr Eye Res 44:135–146
Forsby A, Norman KG, El Andaloussi-Lilja J, Lundqvist J, Walczak V, Curren R, Martin K, Tierney NK (2012) Using novel in vitro NociOcular assay based on TRPV1 channel activation for prediction of eye sting potential of baby shampoos. Toxicol Sci 129:325–331
Foster JW, Wahlin K, Adams SM, Birk DE, Zack DJ, Chakravarti S (2017) Cornea organoids from human induced pluripotent stem cells. Sci Rep 7:41286
Freeman S, Alépée N, Barroso J, Cole T, Compagnoni A, Rubingh C, Eskes C, Lammers J, McNamee P, Pfannenbecker U, Zuang V (2010) Prospective validation study of reconstructed human tissue models for eye irritation testing. Altex 27:255–260
Fukuda K (2020) Corneal fibroblasts: function and markers. Exp Eye Res 200:108229
Funderburgh JL, Mann MM, Funderburgh ML (2003) Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. J Biol Chem 278:45629–45637
Gautheron P, Dukic M, Alix D, Sina JF (1992) Bovine corneal opacity and permeability test: an in vitro assay of ocular irritancy. Fundam Appl Toxicol 18:442–449
Gettings SD, Lordo RA, Hintze KL, Bagley DM, Casterton PL, Chudkowski M, Curren RD, Demetrulias JL, Dipasquale LC, Earl LK, Feder PI, Galli CL, Glaza SM, Gordon VC, Janus J, Kurtz PJ, Marenus KD, Moral J, Pape WJ, Renskers KJ, Rheins LA, Roddy MT, Rozen MG, Tedeschi JP, Zyracki J (1996) The CTFA Evaluation of Alternatives Program: an evaluation of in vitro alternatives to the Draize primary eye irritation test. (Phase III) surfactant-based formulations. Food Chem Toxicol 34:79–117
Ghezzi CE, Rnjak-Kovacina J, Kaplan DL (2015) Corneal tissue engineering: recent advances and future perspectives. Tissue Eng Part B Rev 21:278–287
Gilleron L, Coecke S, Sysmans M, Hansen E, van Oproy S, Marzin D, van Cauteren H, Vanparys P (1997) Evaluation of the HET-CAM-TSA method as an alternative to the draize eye irritation test. Toxicol in Vitro 11:641–644
Gordon S, Daneshian M, Bouwstra J, Caloni F, Constant S, Davies DE, Dandekar G, Guzman CA, Fabian E, Haltner E, Hartung T, Hasiwa N, Hayden P, Kandarova H, Khare S, Krug HF, Kneuer C, Leist M, Lian G, Marx U, Metzger M, Ott K, Prieto P, Roberts MS, Roggen EL, Tralau T, van den Braak C, Walles H, Lehr CM (2015) Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. Altex 32:327–378
Goswami DG, Tewari-Singh N, Agarwal R (2016) Corneal toxicity induced by vesicating agents and effective treatment options. Ann N Y Acad Sci 1374:193–201
Griffith M, Osborne R, Munger R, Xiong X, Doillon CJ, Laycock NL, Hakim M, Song Y, Watsky MA (1999) Functional human corneal equivalents constructed from cell lines. Science 286:2169–2172
Gruber FP, Hartung T (2004) Alternatives to animal experimentation in basic research. Altex 21(Suppl 1):3–31
Guo X, Hutcheon AE, Melotti SA, Zieske JD, Trinkaus-Randall V, Ruberti JW (2007) Morphologic characterization of organized extracellular matrix deposition by ascorbic acid-stimulated human corneal fibroblasts. Invest Ophthalmol Vis Sci 48:4050–4060
Haderspeck JC, Chuchuy J, Kustermann S, Liebau S, Loskill P (2019) Organ-on-a-chip technologies that can transform ophthalmic drug discovery and disease modeling. Expert Opin Drug Disc 14:47–57
Harbell JW, Koontz SW, Lewis RW, Lovell D, Acosta D (1997) IRAG working group 4. Cell cytotoxicity assays. Interagency Regulatory Alternatives Group. Food Chem Toxicol 35:79–126
Hartung T (2009) Toxicology for the twenty-first century. Nature 460:208–212
Hartung T (2010) Food for thought...on alternative methods for chemical safety testing. Altex 27:3–14
Hartung T, De Vries R, Hoffmann S, Hogberg HT, Smirnova L, Tsaioun K, Whaley P, Leist M (2019) Toward good in vitro reporting standards. Altex 36:3–17
Hartung T, Gstraunthaler G, Coecke S, Lewis D, Blanck O, Balls M (2001) Good cell culture practice (GCCP)--an initiative for standardization and quality control of in vitro studies. The establishment of an ECVAM Task Force on GCCP. Altex 18:75–78
Hatou S, Yoshida S, Higa K, Miyashita H, Inagaki E, Okano H, Tsubota K, Shimmura S (2013) Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and Wnt/β-catenin signaling. Stem Cells Dev 22:828–839
Hornof M, Toropainen E, Urtti A (2005) Cell culture models of the ocular barriers. Eur J Pharm Biopharm 60:207–225
Hutak CM, Kavanagh ME, Reddy IK (2002) Comparative development of SIRC rabbit corneal cells grown on polycarbonate- and polyester-based filters. Skin Pharmacol Appl Ski Physiol 15:133–138
Hutcheon AEK, Zieske JD, Guo X (2019) 3D in vitro model for human corneal endothelial cell maturation. Exp Eye Res 184:183–191
ICCVAM (2010a) ICCVAM LVET test method evaluation report: recommendation to discontinue use of the low volume eye test for ocular safety testing. NIH Publication, National Institute of Environmental Heath Sciences, Triangle Park
ICCVAM (2010b) ICCVAM test method evaluation report: current validation status of in vitro test methods proposed for identifying eye injury hazard potential of chemicals and products. NIH. Publication No. 10-7553. National Institute of Environmental Health Sciences, Research Triangle Park,
Jester JV (2006) Extent of corneal injury as a biomarker for hazard assessment and the development of alternative models to the Draize rabbit eye test. Cutan Ocul Toxicol 25:41–54
Jester JV, Ho-Chang J (2003) Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res 77:581–592
Jester JV, Huang J, Fisher S, Spiekerman J, Chang JH, Wright WE, Shay JW (2003) Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts. Invest Ophthalmol Vis Sci 44:1850–1858
Jester JV, Li L, Molai A, Maurer JK (2001) Extent of initial corneal injury as a basis for alternative eye irritation tests. Toxicol in Vitro 15:115–130
Jirova D, Kejlova K, Janousek S, Bendova H, Maly M, Kolarova H, Dvorakova M (2014) Eye irritation hazard of chemicals and formulations assessed by methods in vitro. Neuro Endocrinol Lett 35(Suppl 2):133–140
Jones PA, Bracher M, Marenus K, Kojima H (1999) Performance of the Neutral Red uptake assay in the COLIPA international validation study on alternatives to the rabbit eye irritation test. Toxicol in Vitro 13:325–333
Jones PA, Budynsky E, Cooper KJ, Decker D, Griffiths HA, Fentem JH (2001) Comparative evaluation of five in vitro tests for assessing the eye irritation potential of hair-care products. Altern Lab Anim 29:669–692
Joseph A, Powell-Richards AO, Shanmuganathan VA, Dua HS (2004) Epithelial cell characteristics of cultured human limbal explants. Br J Ophthalmol 88:393–398
Jung KM, Lee SH, Ryu YH, Jang WH, Jung HS, Han JH, Seok SH, Park JH, Son Y, Park YH, Lim KM (2011) A new 3D reconstituted human corneal epithelium model as an alternative method for the eye irritation test. Toxicol in Vitro 25:403–410
Juretic M, Jurisic Dukovski B, Krtalic I, Reichl S, Cetina-Cizmek B, Filipovic-Grcic J, Lovric J, Pepic I (2017) HCE-T cell-based permeability model: a well-maintained or a highly variable barrier phenotype? Eur J Pharm Sci 104:23–30
Kabakov AE, Gabai VL (2018) Cell death and survival assays. Methods Mol Biol 1709:107–127
Kahn CR, Young E, Lee IH, Rhim JS (1993) Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. Invest Ophthalmol Vis Sci 34:3429–3441
Kaluzhny Y, Kandarova H, Handa Y, DeLuca J, Truong T, Hunter A, Kearney P, d'Argembeau-Thornton L, Klausner M (2015) The EpiOcular Eye Irritation Test (EIT) for hazard identification and labelling of eye irritating chemicals: protocol optimisation for solid materials and the results after extended shipment. Altern Lab Anim 43:101–127
Kaluzhny Y, Kandarova H, Hayden P, Kubilus J, d'Argembeau-Thornton L, Klausner M (2011) Development of the EpiOcular(TM) eye irritation test for hazard identification and labelling of eye irritating chemicals in response to the requirements of the EU cosmetics directive and REACH legislation. Altern Lab Anim 39:339–364
Kaluzhny Y, Kinuthia MW, Lapointe AM, Truong T, Klausner M, Hayden P (2020) Oxidative stress in corneal injuries of different origin: utilization of 3D human corneal epithelial tissue model. Exp Eye Res 190:107867
Kaluzhny Y, Kinuthia MW, Truong T, Lapointe AM, Hayden P, Klausner M (2018) New human organotypic corneal tissue model for ophthalmic drug delivery studies. Invest Ophthalmol Vis Sci 59:2880–2898
Kandarova H, Letasiova S, Adriaens E, Guest R, Willoughby JA Sr, Drzewiecka A, Gruszka K, Alepee N, Verstraelen S, Van Rompay AR (2018a) CON4EI: CONsortium for in vitro eye irritation testing strategy - EpiOcular time-to-toxicity (EpiOcular ET-50) protocols for hazard identification and labelling of eye irritating chemicals. Toxicol in Vitro 49:34–52
Kandarova H, Letasiova S, Adriaens E, Guest R, Willoughby JA Sr, Drzewiecka A, Gruszka K, Alepee N, Verstraelen S, Van Rompay AR (2018b) CON4EI: EpiOcular Eye Irritation Test (EpiOcular EIT) for hazard identification and labelling of eye irritating chemicals. Toxicol in Vitro 49:21–33
Karamichos D, Zareian R, Guo X, Hutcheon AE, Ruberti JW, Zieske JD (2012) Novel in vitro model for keratoconus disease. J Funct Biomater 3:760–775
Katoh M, Hamajima F, Ogasawara T, Hata K (2013) Establishment of a new in vitro test method for evaluation of eye irritancy using a reconstructed human corneal epithelial model, LabCyte CORNEA-MODEL. Toxicol in Vitro 27:2184–2192
Kawakita T, Espana EM, He H, Smiddy R, Parel JM, Liu CY, Tseng SC (2006) Preservation and expansion of the primate keratocyte phenotype by downregulating TGF-beta signaling in a low-calcium, serum-free medium. Invest Ophthalmol Vis Sci 47:1918–1927
Kawazu K, Midori Y, Ota A (1999) Cultured rabbit corneal epithelium elicits levofloxacin absorption and secretion. J Pharm Pharmacol 51:791–796
Kim S, Choi KH, Yun J (2018) Exploration of alternative test methods to evaluate phototoxicity of ophthalmic agents by using Statens Seruminstitut Rabbit Cornea cell lines and 3D human reconstituted cornea models. PLoS One 13:e0196735
Kimoto M, Shima N, Yamaguchi M, Hiraoka Y, Amano S, Yamagami S (2014) Development of a bioengineered corneal endothelial cell sheet to fit the corneal curvature. Invest Ophthalmol Vis Sci 55:2337–2343
Klausner M, Hayden P, Breyfogle B, Vellavance K, Osborn M, Cerven D, DeGeorge G, Kubilus J (2003) The epiocular prediction model: a reproducible in vitro means of assessing ocular irritancy. Alternative Toxicological Methods. CRC Press LLC, pp. 131-146
Kojima H, Ando Y, Idehara K, Katoh M, Kosaka T, Miyaoka E, Shinoda S, Suzuki T, Yamaguchi Y, Yoshimura I, Yuasa A, Watanabe Y, Omori T (2012) Validation study of the in vitro skin irritation test with the LabCyte EPI-MODEL24. Altern Lab Anim 40:33–50
Kojima H, Yamaguchi H, Sozu T, Kleinstreuer N, Chae-Hyung L, Chen W, Watanabe M, Fukuda T, Yamashita K, Takezawa T (2019) Multi-laboratory validation study of the Vitrigel-eye irritancy test method as an alternative to in vivo eye irritation testing. Altern Lab Anim 47:140–157
Kolle SN, Sauer UG, Moreno MC, Teubner W, Wohlleben W, Landsiedel R (2016) Eye irritation testing of nanomaterials using the EpiOcular™ eye irritation test and the bovine corneal opacity and permeability assay. Part Fibre Toxicol 13:18
Kolle SN, Van Cott A, van Ravenzwaay B, Landsiedel R (2017) Lacking applicability of in vitro eye irritation methods to identify seriously eye irritating agrochemical formulations: Results of bovine cornea opacity and permeability assay, isolated chicken eye test and the EpiOcular™ ET-50 method to classify according to UN GHS. Regul Toxicol Pharmacol 85:33–47
Kruszewski FH, Walker TL, DiPasquale LC (1997) Evaluation of a human corneal epithelial cell line as an in vitro model for assessing ocular irritation. Fundam Appl Toxicol 36:130–140
Lambert LA, Chambers WA, Green S, Gupta KC, Hill RN, Hurley PM, Lee CC, Lee JK, Liu PT, Lowther DK et al (1993) The use of low-volume dosing in the eye irritation test. Food Chem Toxicol 31:99–103
Lebrun S, Xie Y, Chavez S, Chan R, Jester JV (2019) An in vitro depth of injury prediction model for a histopathologic classification of EPA and GHS eye irritants. Toxicol in Vitro 61:104628
Lee M, Hwang JH, Lim KM (2017) Alternatives to in vivo Draize rabbit eye and skin irritation tests with a focus on 3D reconstructed human cornea-like epithelium and epidermis models. Toxicol Res 33:191–203
Lim SE, Ha SJ, Jang WH, Jung KM, Jung MS, Yeo KW, Kim JS, Jeong TC, Kang MJ, Kim SY, Lee SH, Ko KY, Kim TS, Park KS, Bae S, Lim KM (2019) Me-too validation study for in vitro eye irritation test with 3D-reconstructed human cornea epithelium, MCTT HCE(TM). Toxicol in Vitro 55:173–184
Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, Timofeeva OA, Nealon C, Dakic A, Simic V, Haddad BR, Rhim JS, Dritschilo A, Riegel A, McBride A, Schlegel R (2012) ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am J Pathol 180:599–607
Ljubimov AV, Saghizadeh M (2015) Progress in corneal wound healing. Prog Retin Eye Res 49:17–45
Lotz C, Schmid FF, Rossi A, Kurdyn S, Kampik D, De Wever B, Walles H, Groeber FK (2016) Alternative methods for the replacement of eye irritation testing. Altex 33:55–67
Lu Q, Yin H, Grant MP, Elisseeff JH (2017) An in vitro model for the ocular surface and tear film system. Sci Rep 7:6163
Luechtefeld T, Maertens A, Russo DP, Rovida C, Zhu H, Hartung T (2016) Global analysis of publicly available safety data for 9,801 substances registered under REACH from 2008-2014. Altex 33:95–109
Matsuda S, Hisama M, Shibayama H, Itou N, Iwaki M (2009a) Application of the reconstructed rabbit corneal epithelium model to assess the in-vitro eye irritant test of chemicals. Yakugaku Zasshi 129:1113–1120
Matsuda S, Hisama M, Shibayama H, Itou N, Iwaki M (2009b) In vitro eye irritancy test of lauryl derivatives using the reconstructed rabbit corneal epithelium model. Toxicol in Vitro 23:555–560
Matysik-Woźniak A, Paduch R, Turski WA, Maciejewski R, Jünemann AG, Rejdak R (2017) Effects of tryptophan, kynurenine and kynurenic acid exerted on human reconstructed corneal epithelium in vitro. Pharmacol Rep 69:722–729
Maurer JK, Jester JV (1999) Use of in vivo confocal microscopy to understand the pathology of accidental ocular irritation. Toxicol Pathol 27:44–47
Maurer JK, Parker RD, Jester JV (2002) Extent of initial corneal injury as the mechanistic basis for ocular irritation: key findings and recommendations for the development of alternative assays. Regul Toxicol Pharmacol 36:106–117
McCabe KL, Kunzevitzky NJ, Chiswell BP, Xia X, Goldberg JL, Lanza R (2015) Efficient generation of human embryonic stem cell-derived corneal endothelial cells by directed differentiation. PLoS One 10:e0145266
McCain NE, Binetti RR, Gettings SD, Jones BC (2002) Assessment of ocular irritation ranges of market-leading cosmetic and personal-care products using an in vitro tissue equivalent. Toxicologist 66:243
McConnell HM, Owicki JC, Parce JW, Miller DL, Baxter GT, Wada HG, Pitchford S (1992) The cytosensor microphysiometer: biological applications of silicon technology. Science 257:1906–1912
McKay TB, Karamichos D, Hutcheon AEK, Guo X, Zieske JD (2019) Corneal epithelial-stromal fibroblast constructs to study cell-cell communication in vitro. Bioengineering (Basel) 6
Meloni M, De Servi B, Marasco D, Del Prete S (2011) Molecular mechanism of ocular surface damage: application to an in vitro dry eye model on human corneal epithelium. Mol Vis 17:113–126
Michelle L (2020) US states join global push to ban animal-tested cosmetics. https://abcnews.go.com/Business/wireStory/us-states-join-global-push-ban-animal-tested-68690876. PRICE Associate Press
Mohan RR, Possin DE, Mohan RR, Sinha S, Wilson SE (2003) Development of genetically engineered tet HPV16-E6/E7 transduced human corneal epithelial clones having tight regulation of proliferation and normal differentiation. Exp Eye Res 77:395–407
Morrison PW, Khutoryanskiy VV (2014) Advances in ophthalmic drug delivery. Ther Deliv 5:1297–1315
Mou H, Vinarsky V, Tata PR, Brazauskas K, Choi SH, Crooke AK, Zhang B, Solomon GM, Turner B, Bihler H, Harrington J, Lapey A, Channick C, Keyes C, Freund A, Artandi S, Mense M, Rowe S, Engelhardt JF, Hsu YC, Rajagopal J (2016) Dual SMAD signaling inhibition enables long-term expansion of diverse epithelial basal cells. Cell Stem Cell 19:217–231
Nakahara S, Kojima H, Omori T, UYamashita A, Endo M, Satake M, Kasahara T et al (2019) A validation study of a new in vitro eye irritation test using the reconstructed human corneal epithelial tissue, LabCyte CORNEA-MODEL24. AATEX 24:11–23
Nakamura T, Teshima M, Kitahara T, Sasaki H, Uematsu M, Kitaoka T, Nakashima M, Nishida K, Nakamura J, Higuchi S (2010) Sensitive and real-time method for evaluating corneal barrier considering tear flow. Biol Pharm Bull 33:107–110
Narda M, Ramos-Lopez D, Mun G, Valderas-Martinez P, Granger C (2019) Three-tier testing approach for optimal ocular tolerance sunscreen. Cutan Ocul Toxicol 38:212–220
Narsineni L, Foldvari M (2020) Dicationic amino substituted gemini surfactants and their nanoplexes: improved synthesis and characterization of transfection efficiency and corneal penetration in vitro. Pharm Res 37:144
NIEHS & NIH (2007) Request for ocular irritancy test data from human, rabbit, and in vitro studies using standardized testing methods. Fed Regist 31:582–531,583
Niranjan P, Dang AH, January BG, Gomez C, Harbell JW (2007) Use of the EpiOcular assay for preclinical qualification of formulas for human clinical studies. Toxicologist 96
OECD (2012) Draft OECD guideline for the testing of chemicals: the cytosensor microphysiometer test method: an in vitro method for identifying ocular corrosive and severe irritant chemicals as well as chemicals not classified as ocular irritants. OECD Publishing,
OECD (2017a) Test No. 405: acute eye irritation/corrosion. OECD Guidelines for the Testing of Chemicals. OECD Publishing, https://www.oecd.org/env/test-no-405-acute-eye-irritation-corrosion-9789264185333-en.htm; https://doi.org/10.1787/9789264203860-en
OECD (2017b) Test No. 437. Bovine corneal opacity and permeability test: an in vitro assay of ocular irritancy. OECD Publishing, https://doi.org/10.1787/9789264203846-en
OECD (2017c) Test No. 460: fluorescein leakage test method for identifying ocular corrosives and severe irritants. OECD Publishing, https://doi.org/10.1787/9789264185401-en
OECD (2018a) Guidance document on an integrated approach on testing and assessment for serious eye damage and eye irritation. OECD Publishing,
OECD (2018b) Test No. 438. Isolated chicken eye test method for identifying i) chemicals inducing serious eye damage and ii) chemicals not requiring classification for eye irritation or serious eye damage. OECD Publishing, https://doi.org/10.1787/20745788
OECD (2018c) Test No. 491. Draft guideline for the testing of chemicals. The short time exposure in vitro test method for identifying i) chemicals inducing serious eye damage and ii) chemicals not requiring classification for eye irritation or serious eye damage. OECD Guidelines for the Testing of Chemicals. OECD Publishing, https://doi.org/10.1787/9789264242432-en
OECD (2019a) Test No. 492. Reconstructed human cornea-like epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage. OECD Publishing, https://doi.org/10.1787/20745788
OECD (2019b) Test No. 494: Vitrigel-eye irritancy test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage. OECD Publishing, https://doi.org/10.1787/20745788
Olivieri M, Cristaldi M, Pezzino S, Rusciano D, Tomasello B, Anfuso CD, Lupo G (2018) Phenotypic characterization of the SIRC (Statens Seruminstitut Rabbit Cornea) cell line reveals a mixed epithelial and fibroblastic nature. Exp Eye Res 172:123–127
OSHA (2009) Foundation of workplace chemical safety programs. Available at: https://www.osha.gov/dsg/hazcom/global.html, accessed on July 13, 2020.
Palchesko RN, Lathrop KL, Funderburgh JL, Feinberg AW (2015) In vitro expansion of corneal endothelial cells on biomimetic substrates. Sci Rep 5:7955
Parish ST, Aschner M, Casey W, Corvaro M, Embry MR, Fitzpatrick S, Kidd D, Kleinstreuer NC, Lima BS, Settivari RS, Wolf DC, Yamazaki D, Boobis A (2020) An evaluation framework for new approach methodologies (NAMs) for human health safety assessment. Regul Toxicol Pharmacol 112:104592
Pauwels M, Rogiers V (2007) EU legislations affecting safety data availability of cosmetic ingredients. Regul Toxicol Pharmacol 49:308–315
Pawar PK, Majumdar DK (2006) Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas. AAPS PharmSciTech 7:E13
Pepic I, Lovric J, Cetina-Cizmek B, Reichl S, Filipovic-Grcic J (2014) Toward the practical implementation of eye-related bioavailability prediction models. Drug Discov Today 19:31–44
Pfannenbecker U, Bessou-Touya S, Faller C, Harbell J, Jacob T, Raabe H, Tailhardat M, Alepee N, De Smedt A, De Wever B, Jones P, Kaluzhny Y, Le Varlet B, McNamee P, Marrec-Fairley M, Van Goethem F (2013) Cosmetics Europe multi-laboratory pre-validation of the EpiOcular reconstituted human tissue test method for the prediction of eye irritation. Toxicol in Vitro 27:619–626
Piehl M, Carathers M, Soda R, Cerven D, DeGeorge G (2011) Porcine Corneal Ocular Reversibility Assay (PorCORA) predicts ocular damage and recovery for global regulatory agency hazard categories. Toxicol in Vitro 25:1912–1918
Postnikoff CK, Pintwala R, Williams S, Wright AM, Hileeto D, Gorbet MB (2014) Development of a curved, stratified, in vitro model to assess ocular biocompatibility. PLoS One 9:e96448
Prabst K, Engelhardt H, Ringgeler S, Hubner H (2017) Basic colorimetric proliferation assays: MTT, WST, and Resazurin. Methods Mol Biol 1601:1–17
Prausnitz MR, Noonan JS (1998) Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 87:1479–1488
Prinsen MK (1996) The chicken enucleated eye test (CEET): a practical (pre)screen for the assessment of eye irritation/corrosion potential of test materials. Food Chem Toxicol 34:291–296
Purssell A, Lau R, Boggild AK (2017) Azithromycin and doxycycline attenuation of Acanthamoeba virulence in a human corneal tissue model. J Infect Dis 215:1303–1311
Ramaesh K, Dhillon B (2003) Ex vivo expansion of corneal limbal epithelial/stem cells for corneal surface reconstruction. Eur J Ophthalmol 13:515–524
Reader SJ, Blackwell V, O'Hara R, Clothier RH, Griffin G, Balls M (1990) Neutral red release from pre-loaded cells as an in vitro approach to testing for eye irritancy potential. Toxicol in Vitro 4:264–266
Reichl S (2008) Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro. J Pharm Pharmacol 60:299–307
Reichl S, Bednarz J, Muller-Goymann CC (2004) Human corneal equivalent as cell culture model for in vitro drug permeation studies. Br J Ophthalmol 88:560–565
Reichl S, Dohring S, Bednarz J, Muller-Goymann CC (2005) Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas. Eur J Pharm Biopharm 60:305–308
Reichl S, Kolln C, Hahne M, Verstraelen J (2011) In vitro cell culture models to study the corneal drug absorption. Expert Opin Drug Metab Toxicol 7:559–578
Reichl S, Muller-Goymann CC (2003) The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride. Int J Pharm 250:191–201
Roggeband R, York M, Pericoi M, Braun W (2000) Eye irritation responses in rabbit and man after single applications of equal volumes of undiluted model liquid detergent products. Food Chem Toxicol 38:727–734
Ronkko S, Vellonen KS, Jarvinen K, Toropainen E, Urtti A (2016) Human corneal cell culture models for drug toxicity studies. Drug Deliv Transl Res 6:660–675
Sareen D, Saghizadeh M, Ornelas L, Winkler MA, Narwani K, Sahabian A, Funari VA, Tang J, Spurka L, Punj V, Maguen E, Rabinowitz YS, Svendsen CN, Ljubimov AV (2014) Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium. Stem Cells Transl Med 3:1002–1012
Schermer A, Galvin S, Sun TT (1986) Differentiation-related expression of a major 64 K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol 103:49–62
Schneider AI, Maier-Reif K, Graeve T (1999) Constructing an in vitro cornea from cultures of the three specific corneal cell types. In Vitro Cell Dev Biol Anim 35:515–526
Scott L, Eskes C, Hoffmann S, Adriaens E, Alepee N, Bufo M, Clothier R, Facchini D, Faller C, Guest R, Harbell J, Hartung T, Kamp H, Varlet BL, Meloni M, McNamee P, Osborne R, Pape W, Pfannenbecker U, Prinsen M, Seaman C, Spielmann H, Stokes W, Trouba K, Berghe CV, Goethem FV, Vassallo M, Vinardell P, Zuang V (2010) A proposed eye irritation testing strategy to reduce and replace in vivo studies using bottom-up and top-down approaches. Toxicol in Vitro 24:1–9
Seo J, Byun WY, Alisafaei F, Georgescu A, Yi YS, Massaro-Giordano M, Shenoy VB, Lee V, Bunya VY, Huh D (2019) Multiscale reverse engineering of the human ocular surface. Nat Med 25:1310–1318
Settivari RS, Amado RA, Corvaro M, Visconti NR, Kan L, Carney EW, Boverhof DR, Gehen SC (2016) Tiered application of the neutral red release and EpiOcular™ assays for evaluating the eye irritation potential of agrochemical formulations. Regul Toxicol Pharmacol 81:407–420
Shafaie S, Hutter V, Cook MT, Brown MB, Chau DY (2016) In vitro cell models for ophthalmic drug development applications. Biores Open Access 5:94–108
Sharif R, Priyadarsini S, Rowsey TG, Ma JX, Karamichos D (2018) Corneal tissue engineering: an in vitro model of the stromal-nerve interactions of the human cornea. J Vis Exp. https://doi.org/10.3791/56308
Sheasgreen J, Klausner M, Kandarova H, Ingalls D (2009) The MatTek story - how the three Rs principles led to 3-D tissue success! Altern Lab Anim 37:611–622
Shima N, Kimoto M, Yamaguchi M, Yamagami S (2011) Increased proliferation and replicative lifespan of isolated human corneal endothelial cells with L-ascorbic acid 2-phosphate. Invest Ophthalmol Vis Sci 52:8711–8717
Silk JC (2003) Development of a globally harmonized system for hazard communication. Int J Hyg Environ Health 206:447–452
Siran W, Ghezzi CE, Cairns DM, Pollard RE, Chen Y, Gomes R, McKay TB, Pouli D, Jamali A, Georgakoudi I, Funderburgh JL, Kenyon K, Hamrah P, Kaplan DL (2018) Human corneal tissue model for nociceptive assessments. Adv Healthc Mater 7:e1800488
Sosnová-Netuková M, Kuchynka P, Forrester JV (2007) The suprabasal layer of corneal epithelial cells represents the major barrier site to the passive movement of small molecules and trafficking leukocytes. Br J Ophthalmol 91:372–378
Spielmann H, Liebsch M, Moldenhauer F, Holzhutter HG, de Silva O (1995) Modern biostatistical methods for assessing in vitro/in vivo correlation of severely eye irritating chemicals in a validation study of in vitro alternatives to the Draize eye test. Toxicol in Vitro 9:549–556
Spöler F, Kray O, Kray S, Panfil C, Schrage NF (2015) The ex vivo eye irritation test as an alternative test method for serious eye damage/eye irritation. Altern Lab Anim 43:163–179
Stepanenko AA, Kavsan VM (2012) Immortalization and malignant transformation of eukaryotic cells. Tsitol Genet 46:36–75
Stephens ML, Mak NS et al (2013) History of the 3Rs in toxicity testing: from Russell and Burch to 21st century toxicology. In: Allen D, Walters M (eds) Reducing, refining and replacing the use of animals in toxicity testing. RSC, Publishing, Cambridge, pp 1–39
Stern M, Klausner M, Alvarado R, Renskers K, Dickens M (1998) Evaluation of the EpiOcular TM tissue model as an alternative to the Draize eye irritation test. Toxicol in Vitro 12:455–461
Sun CC, Chiu HT, Lin YF, Lee KY, Pang JH (2015) Y-27632, a ROCK inhibitor, promoted limbal epithelial cell proliferation and corneal wound healing. PLoS One 10:e0144571
Susaimanickam PJ, Maddileti S, Pulimamidi VK, Boyinpally SR, Naik RR, Naik MN, Reddy GB, Sangwan VS, Mariappan I (2017) Generating minicorneal organoids from human induced pluripotent stem cells. Development 144:2338–2351
Suuronen EJ, McLaughlin CR, Stys PK, Nakamura M, Munger R, Griffith M (2004) Functional innervation in tissue engineered models for in vitro study and testing purposes. Toxicol Sci 82:525–533
Takahashi Y, Hayashi K, Abo T, Koike M, Sakaguchi H, Nishiyama N (2011) The Short Time Exposure (STE) test for predicting eye irritation potential: intra-laboratory reproducibility and correspondence to globally harmonized system (GHS) and EU eye irritation classification for 109 chemicals. Toxicol in Vitro 25:1425–1434
Takahashi Y, Koike M, Honda H, Ito Y, Sakaguchi H, Suzuki H, Nishiyama N (2008) Development of the short time exposure (STE) test: an in vitro eye irritation test using SIRC cells. Toxicol in Vitro 22:760–770
Takezawa T, Nishikawa K, Wang PC (2011) Development of a human corneal epithelium model utilizing a collagen vitrigel membrane and the changes of its barrier function induced by exposing eye irritant chemicals. Toxicol in Vitro 25:1237–1241
Tegtmeyer S, Papantoniou I, Muller-Goymann CC (2001) Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride. Eur J Pharm Biopharm 51:119–125
Thakur A, Clegg A, Chauhan A, Willcox MD (1997) Modulation of cytokine production from an EpiOcular corneal cell culture model in response to Staphylococcus aureus superantigen. Aust N Z J Ophthalmol 25(Suppl 1):S43–S45
Toropainen E, Ranta VP, Talvitie A, Suhonen P, Urtti A (2001) Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophthalmol Vis Sci 42:2942–2948
U.S.Congress (2017) H.R.2790 - Humane Cosmetics Act, 115th Congress. Rep. McSally, Martha (Introduced 06/06/2017). Available at. https://www.congress.gov/bill/115th-congress/house-bill/2790. House - Energy and Commerce,
Uematsu M, Mohamed YH, Onizuka N, Ueki R, Inoue D, Fujikawa A, Kitaoka T (2015) A novel in vivo corneal trans-epithelial electrical resistance measurement device. J Pharmacol Toxicol Methods 76:65–71
Uematsu M, Mohamed YH, Onizuka N, Ueki R, Inoue D, Fujikawa A, Sasaki H, Kitaoka T (2016) Less invasive corneal transepithelial electrical resistance measurement method. Ocul Surf 14:37–42
UN (2003) Globally Harmonized System of classification and labeling of chemicals (GHS) 8th revision, 2019, http://www.unece.org/trans/danger/publi/ghs/ghs_rev08/08files_e.html (Accessed May 1, 2020).
UN (2017) United Nations Globally Harmonized System of Classification and Labelling of Chemicals (GHS). Seventh Revised Edition, Availa-ble at: [http://www.unece.org/fileadmin/DAM/trans/danger/publi/ghs/ghs_rev07/English /ST-SG-AC10-30- Rev7e.pdf]. New York and Geneva: United Nations,
Van den Berghe C, Guillet MC, Compan D (2005) Performance of porcine corneal opacity and permeability assay to predict eye irritation for water-soluble cosmetic ingredients. Toxicol in Vitro 19:823–830
Van den Bogerd B, Zakaria N, Adam B, Matthyssen S, Koppen C, Ni Dhubhghaill S (2019) Corneal endothelial cells over the past decade: are we missing the mark(er)? Transl Vis Sci Technol 8:13
Van Goethem F, Adriaens E, Alepee N, Straube F, De Wever B, Cappadoro M, Catoire S, Hansen E, Wolf A, Vanparys P (2006) Prevalidation of a new in vitro reconstituted human cornea model to assess the eye irritating potential of chemicals. Toxicol in Vitro 20:1–17
Van Rompay AR, Alepee N, Nardelli L, Hollanders K, Leblanc V, Drzewiecka A, Gruszka K, Guest R, Kandarova H, Willoughby JA Sr, Verstraelen S, Adriaens E (2018) CON4EI: SkinEthic Human Corneal Epithelium Eye Irritation Test (SkinEthic HCE EIT) for hazard identification and labelling of eye irritating chemicals. Toxicol in Vitro 49:11–20
Vellonen KS, Mannermaa E, Turner H, Hakli M, Wolosin JM, Tervo T, Honkakoski P, Urtti A (2010) Effluxing ABC transporters in human corneal epithelium. J Pharm Sci 99:1087–1098
Verstraelen S, Maglennon G, Hollanders K, Boonen F, Adriaens E, Alepee N, Drzewiecka A, Gruszka K, Kandarova H, Willoughby JA Sr, Guest R, Schofield J, Van Rompay AR (2017) CON4EI: Bovine Corneal Opacity and Permeability (BCOP) test for hazard identification and labelling of eye irritating chemicals. Toxicol in Vitro 44:122–133
Verstraelen S, Maglennon G, Hollanders K, Boonen F, Adriaens E, Alepee N, Drzewiecka A, Gruszka K, Kandarova H, Willoughby JA Sr, Guest R, Schofield J, Van Rompay AR (2018) Reprint of “CON4EI: Bovine Corneal Opacity and Permeability (BCOP) test for hazard identification and labelling of eye irritating chemicals”. Toxicol in Vitro 49:53–64
Verstraelen S, Van Rompay AR (2018) CON4EI: development of serious eye damage and eye irritation testing strategies with respect to the requirements of the UN GHS/EU CLP hazard categories. Toxicol in Vitro 49:2–5
Vitrigel-EIT-VMT (2017) Validation study of the Vitrigel-EIT method as an alternative to in vivo eye irritation testing. Study report, Version 2. March 25, 2017. VITRIGEL-EIT Validation Management Team (VMT); avaliable at: https://www.jacvam.jp/files/list/06/06_09_D1.pdf.
Wang S, Ghezzi CE, Gomes R, Pollard RE, Funderburgh JL, Kaplan DL (2017) In vitro 3D corneal tissue model with epithelium, stroma, and innervation. Biomaterials 112:1–9
Wilson SL, Ahearne M, Hopkinson A (2015) An overview of current techniques for ocular toxicity testing. Toxicology 327:32–46
Wu J, Du Y, Mann MM, Funderburgh JL, Wagner WR (2014) Corneal stromal stem cells versus corneal fibroblasts in generating structurally appropriate corneal stromal tissue. Exp Eye Res 120:71–81
Wu X, Wang S, Li M, Li J, Shen J, Zhao Y, Pang J, Wen Q, Chen M, Wei B, Kaboli PJ, Du F, Zhao Q, Cho CH, Wang Y, Xiao Z, Wu X (2020) Conditional reprogramming: next generation cell culture. Acta Pharm Sin B 10:1360–1381
www.allaboutvision.com (2020) The anatomy and the structure of the human eye and the cornea. Accessed on July 24, 2020., https://www.allaboutvision.com/resources/anatomy.htm and https://www.allaboutvision.com/resources/cornea.htm,
www.episkin.com (2020) SkinEthic HCE / Corneal Epithelium; https://www.episkin.com/HCE-Corneal-Epithelium (accessed September 28, 2020).
www.jpte.co.jp (2020) LabCyte CORNEA-MODEL; http://www.jpte.co.jp/english/business/LabCyte/CORNEAmodel.html; (accessed September 28, 2020).
www.keraskin.co.kr (2020) MCTT HCE™ Mucosal model; http://www.keraskin.co.kr/product/mucosalmodel.asp; (accessed September 28, 2020).
www.mattek.com (2020) EpiOcuar-TM; https://www.mattek.com/products/epiocular/; (accessed September 28, 2020).
Xiang CD, Batugo M, Gale DC, Zhang T, Ye J, Li C, Zhou S, Wu EY, Zhang EY (2009) Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport. Drug Metab Dispos 37:992–998
Xie HT, Chen SY, Li GG, Tseng SC (2012) Isolation and expansion of human limbal stromal niche cells. Invest Ophthalmol Vis Sci 53:279–286
Xu ZZ, Li ZJ, Du LX, Li J, Wang LY (2013) Using bovine pituitary extract to increase proliferation of keratocytes and maintain their phenotype in vitro. Int J Ophthalmol 6:758–765
Yam GH, Yusoff NZ, Kadaba A, Tian D, Myint HH, Beuerman RW, Zhou L, Mehta JS (2015) Ex vivo propagation of human corneal stromal “activated keratocytes” for tissue engineering. Cell Transplant 24:1845–1861
Yamaguchi H, Kojima H, Takezawa T (2013) Vitrigel-eye irritancy test method using HCE-T cells. Toxicol Sci 135:347–355
Yamaguchi H, Kojima H, Takezawa T (2016) Predictive performance of the Vitrigel-eye irritancy test method using 118 chemicals. J Appl Toxicol 36:1025–1037
Yamaguchi H, Takezawa T (2018) Fabrication of a corneal model composed of corneal epithelial and endothelial cells via a collagen Vitrigel membrane functioned as an acellular stroma and its application to the corneal permeability test of chemicals. Drug Metab Dispos 46:1684–1691
Yamaguchi M, Shima N, Kimoto M, Ebihara N, Murakami A, Yamagami S (2015) Markers for distinguishing cultured human corneal endothelial cells from corneal stromal myofibroblasts. Curr Eye Res 40:1211–1217
Yamaguchi T (2018) Inflammatory response in dry eye. Invest Ophthalmol Vis Sci 59:Des192–des199
Yamasaki K, Kawasaki S, Young RD, Fukuoka H, Tanioka H, Nakatsukasa M, Quantock AJ, Kinoshita S (2009) Genomic aberrations and cellular heterogeneity in SV40-immortalized human corneal epithelial cells. Invest Ophthalmol Vis Sci 50:604–613
Yang H, Kim DE, Jang WH, An S, Cho SA, Jung MS, Lee JE, Yeo KW, Koh SB, Jeong TC, Kang MJ, Chun YJ, Lee SH, Lim KM, Bae S (2017) Prevalidation trial for a novel in vitro eye irritation test using the reconstructed human cornea-like epithelial model, MCTT HCE™. Toxicol in Vitro 39:58–67
Ye DJ, Kwon YJ, Baek HS, Shin S, Lee C, Yun JW, Nam KT, Lim KM, Chun YJ (2018) Discovery of ezrin expression as a potential biomarker for chemically induced ocular irritation using human corneal epithelium cell line and a reconstructed human cornea-like epithelium model. Toxicol Sci 165:335–346
Yeung DT, Harper JR, Platoff GE Jr (2020) Supporting fundamental chemical toxicology research to inform medical countermeasure developments: the National Institutes of Health Chemical Countermeasures Research Program. Chem Res Toxicol. https://doi.org/10.1021/acs.chemrestox.0c00086
Zaki AA, Elalfy MS, Said DG, Dua HS (2015) Deep anterior lamellar keratoplasty--triple procedure: a useful clinical application of the pre-Descemetʼs layer (Duaʼs layer). Eye (Lond) 29:323–326
Zhang T, Xiang CD, Gale D, Carreiro S, Wu EY, Zhang EY (2008) Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition. Drug Metab Dispos 36:1300–1307
Zhao JJ, Afshari NA (2016) Generation of human corneal endothelial cells via in vitro ocular lineage restriction of pluripotent stem cells. Invest Ophthalmol Vis Sci 57:6878–6884
Zhao W, Han L, Bae Y, Manickam DS (2019) Lucifer Yellow - a robust paracellular permeability marker in a cell model of the human blood-brain barrier. J Vis Exp. https://doi.org/10.3791/58900
Zhu Q, Zhu Y, Tighe S, Liu Y, Hu M (2019) Engineering of human corneal endothelial cells in vitro. Int J Med Sci 16:507–512
Zorn-Kruppa M, Tykhonova S, Belge G, Bednarz J, Diehl HA, Engelke M (2005) A human corneal equivalent constructed from SV40-immortalised corneal cell lines. Altern Lab Anim 33:37–45
Zuang V (2001) The neutral red release assay: a review. Altern Lab Anim 29:575–599
Zuang V, Eskes C, Griesinger C, Hartung T (2008) ECVAM key area topical toxicity: update on activities. Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences. Japanese Society for Alternatives to Animal Experiments. AATEX 14:523–528
Zuang V, Schäffer M, Tuomainen A, Amcoff P, et al. (2013) EURL ECVAM progress report on the development, validation and regulatory acceptance of alternative methods (2010-2013). Prepared in the framework of Directive 76/768/EEC and Regulation (EC) No 1223/2009 on cosmetic products. European Commission, Joint Research Centre Institute for Health and Consumer Protection, doi:https://doi.org/10.2788/90736
Acknowledgments
The authors thank Dr. Silvia Letasiova of MatTek IVLSL and Jennifer Molignano of MatTek Corporation for reviewing and editing the manuscript. The EpiCorneal tissue model was developed in part using funds from SBIR grant #R44 ES020074 from the Department of Health and Human Services of the National Institute of Environmental Health Sciences (Bethesda, MD).
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: Tetsuji Okamoto
Rights and permissions
About this article
Cite this article
Kaluzhny, Y., Klausner, M. In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development. In Vitro Cell.Dev.Biol.-Animal 57, 207–237 (2021). https://doi.org/10.1007/s11626-020-00533-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-020-00533-7